Gateway to Resources
Streamlining access to Medical Services
Welcome to Your Gateway to Resources: a unique portal from Cangene bioPharma that is designed to make it easier for you to achieve your everyday treatment goals by centralizing access to the most comprehensive
disease- and treatment-related information.
This portal will provide you with a virtual repository of information on immune thrombocytopenic purpura (ITP)
and hepatitis B virus (HBV) liver transplantation.
Our expertise will enhance your experience through a simplified route to current literature, patient assistance programs and reimbursement information, valuable
patient tools, and other dynamic features and benefits.
Healthcare Professionals/Products
Learn about WinRho® SDF
[RhO(D) Immune Globulin Intravenous (Human)]
Prescribing Information
Please click here for Important Risk Information
Learn about HepaGam B®
[Hepatitis B Immune Globulin Intravenous (Human)]
Prescribing Information
Please click here for Important Risk Information
Products & Services
Utilizing Your Gateway to Resources opens you up to a more efficient route to specific disease-related information.
Your Gateway features materials on treatment options, disease primers, key opinion leader discussions, slide programs/workbooks, and educational tools.
In addition, you can easily connect with real-time support on patient assistance programs, reimbursement guidance, medical/scientific affairs, and even request a visit from a Product Specialist.
Cangene bioPharma Specialty Products
About WinRho®
SDF [RhO(D) Immune Globulin Intravenous (Human)]
Prescribing Information
WinRho SDF Mechanism of Action
WinRho SDF Treatment Guide
ITP Insights: A clinical case study video in immune thrombocytopenia
WinRho SDF Case Study Series
Adult Chronic ITP Case 1
Adult Chronic ITP Case 2
Pediatric ITP Case 3
Management of ITP in Pediatrics: An Overview by Dr. Michael Tarantino
Accompanying Workbook
Material Safety Data Sheet (MSDS)
www.WinRho.com
About HepaGam B®
[Hepatitis B Immune
Globulin Intravenous (Human)]
Prescribing Information
HepaGam B Product Overview
HepaGam B Value and Commitment
HepaGam B Dosing Guide
Post-Liver Transplant Resource Guide
Patient Diary/Appointment Book
Material Safety Data Sheet
www.HepaGamB.com
Assistance
Patient Assistance Program
Reimbursement Assistance
For information and answers to questions about reimbursement for HepaGam B and WinRho SDF, please contact customer service at the toll-free numbers below:
1-877-HEPAGAMB
(1-877-437-2426)
1-800-4-WINRHO
(1-800-494-6746)
Reimbursement Card
Medical Education & Support
Distributors/Wholesalers
Distributors
ASD Healthcare,
AmerisourceBergen
Specialty Group
BDI Pharma
BioCare Medical
FFF Enterprises
Florida Infusion
McKesson Specialty,
Plasma & Biologics
National Hospital Specialties
Nōvis Pharmaceuticals
Oncology Supply,
AmerisourceBergen
Specialty Group
Wholesalers
AmerisourceBergen
Cardinal Health
H.D. Smith
McKesson
Morris Dickson
Therapeutic Expertise
As a leader in the marketing and distribution of plasma-derived products, Cangene bioPharma has collected an extensive volume of clinical data regarding the management of immune thrombocytopenic purpura (ITP) and the prevention of hepatitis B virus (HBV) recurrence following liver transplantation.
Your Gateway to Resources serves as an important online repository of clinical data with links to complementary information that will help support the management of your patients with these diseases.
ITP
ITP Educational Guide
Publications
A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Author: Andrew M, et al
Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect.
Author: Bussel J, et al
Standard-dose intravenous anti-D immunoglobulin versus intravenous immmunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Author: Papagianni A, et al
Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: The New York hospital experience.
Author: Scaradavou A.
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Author: Tarantino MD, et al
Order publications through Medical Affairs
Liver Transplantation & HBV
Liver Transplant Educational Guide
Publications
Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation.
Author: Pauwelyn K, et al
Evaluation of blood glucose levels after hepatitis B immune globulin administration utilizing two different blood glucose monitoring systems.
Author: Shetty K, et al
HepaGam B after liver transplant in patients with hepatitis B virus.
Author: Terrault NA, et al
Order publications through Medical Affairs
Healthcare Professionals
Cangene bioPharma partners with healthcare professionals to provide valuable links to important clinical materials that will help to keep you informed about ITP and HBV liver transplantation.
Your Gateway to Resources can support you in achieving your treatment goals by providing product-specific and educational materials, as well as access to organizations that can be shared with your clinical team.
Medical Education
Programs
Management of ITP in Pediatrics: An Overview by Dr. Michael Tarantino
Accompanying Workbook
Disease Awareness
ITP Educational Guide
Liver Transplant Educational Guide
About WinRho® SDF
[RhO(D) Immune Globulin Intravenous (Human)]
Publications
A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Author: Andrew M, et al
Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect.
Author: Bussel J, et al
Standard-dose intravenous anti-D immunoglobulin versus intravenous immmunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Author: Papagianni A, et al
Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: The New York hospital experience.
Author: Scaradavou A.
Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Author: Tarantino MD, et al
Order publications through
Medical Affairs
About HepaGam B®
[Hepatitis B Immune Globulin Intravenous (Human)]
Publications
Outcomes of long-term administration of intravenous hepatitis B immunoglobulins for the prevention of recurrent hepatitis B after liver transplantation.
Author: Pauwelyn K, et al
Evaluation of blood glucose levels after hepatitis B immune globulin administration utilizing two different blood glucose monitoring systems.
Author: Shetty K, et al
HepaGam B after liver transplant in patients with hepatitis B virus.
Author: Terrault NA, et al
Order publications through
Medical Affairs
Patient Management Tools
Pediatric ITP Patient Booklet
Post-Liver Transplant Resource Guide
Patient Diary/Appointment Book
Patient Assistance Program
Reimbursement Assistance
Reimbursement Card
Helpful Organizations
and Resources
ITP Organizations
American Society of Hematology
Association of Pediatric Hematology/Oncology Nurses
Children’s Cancer and Blood Foundation
Hematology Oncology Pharmacy Association
ITP Foundation
Oncology Nursing Society
Platelet Disorder Support
Association
HBV Liver Transplant Organizations
American Association for the Study of Liver Diseases
American College of Clinical Pharmacy
American Liver Foundation
European Association for the Study of the Liver
Hepatitis B Foundation
International Liver Transplantation Society
International Nurses Transplant Society
National Digestive Diseases Information Clearinghouse
Distributors/ Wholesalers
Distributors
ASD Healthcare, AmerisourceBergen
Specialty Group
BDI Pharma
BioCare Medical
FFF Enterprises
Florida Infusion
McKesson Specialty,
Plasma & Biologics
National Hospital Specialties
Nōvis Pharmaceuticals
Oncology Supply, AmerisourceBergen
Specialty Group
Wholesalers
AmerisourceBergen
Cardinal Health
H.D. Smith
McKesson
Morris Dickson
Contact Cangene
1-877-HEPAGAMB
(1-877-437-2426)
1-800-4-WINRHO
(1-800-494-6746)
Patient & Caregiver Resources
As a leader in the marketing and distribution of plasma-derived products, Cangene bioPharma recognizes the need to partner with healthcare professionals, patients, and caregivers to raise awareness of disease management.
Your Gateway to Resources provides valuable educational support for patients and caregivers to better understand the successful management of immune thrombocytopenic purpura (ITP) and the prevention of hepatitis B virus (HBV) recurrence following liver transplantation.
WinRho® SDF
[RhO(D) Immune Globulin Intravenous (Human)]
Resources
Pediatric ITP Patient Booklet
Organizations
Children’s Cancer and Blood Foundation
ITP Foundation
Platelet Disorder Support Association
HepaGam B®
[Hepatitis B Immune Globulin Intravenous (Human)]
Resources
Post-Liver Transplant Resource Guide
Patient Diary/Appointment Book
Organizations
American Liver Foundation
Hepatitis B Foundation
National Digestive Diseases Information Clearinghouse
Reimbursement Assistance
For information and answers to questions about reimbursement for HepaGam B and WinRho SDF, please contact customer service at the toll-free numbers below:
1-877-HEPAGAMB
(1-877-437-2426)
1-800-4-WINRHO
(1-800-494-6746)
Reimbursement Card
Patient Assistance Program
Patients may qualify for temporary assistance for HepaGam B® or
WinRho® SDF therapy while
seeking alternative insurance
coverage. To inquire about
eligibility, please call
1-877-HEPAGAMB
(1-877-437-2426)
1-800-4-WINRHO
(1-800-494-6746)
About Cangene bioPharma
Cangene bioPharma was built on the premise of advancing the care of patients with rare diseases and conditions, by offering FDA-approved treatments, like WinRho® SDF [RhO(D) Immune Globulin Intravenous (Human)] and HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)].
In addition, with the goal of exceptional customer service, Your Gateway to Resources is structured so that you can share important clinical information about disease state management and the respective treatments with staff, patients, and caregivers.
Medical Affairs
medicalaffairs@cangene.com
Customer Service
customerservice@cangene.com
1-877-HEPAGAMB
(1-877-437-2426)
1-800-4-WINRHO
(1-800-494-6746)
Contact a Product Specialist
Request a callback or visit
customerservice@cangene.com
Distributors/Wholesalers
Distributors
ASD Healthcare,
AmerisourceBergen
Specialty Group
BDI Pharma
BioCare Medical
FFF Enterprises
Florida Infusion
McKesson Specialty,
Plasma & Biologics
National Hospital Specialties
Nōvis Pharmaceuticals
Oncology Supply,
AmerisourceBergen
Specialty Group
Wholesalers
AmerisourceBergen
Cardinal Health
H.D. Smith
McKesson
Morris Dickson
Connect to Cangene Corporation
www.cangene.com
